Oliveros, Gilbert .
HRN: 24-05-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/12/2023
11/18/2023
IV
630mg
Q24h
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes